Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1984 1
1988 2
1989 1
1990 3
1991 2
1994 3
1995 4
1996 4
1998 2
1999 1
2003 3
2004 3
2005 6
2006 7
2007 6
2008 6
2009 8
2010 6
2011 16
2012 11
2013 8
2014 8
2015 11
2016 13
2017 13
2018 12
2019 10
2020 13
2021 6
2022 8
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

179 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapeutic options for pancreatic ductal adenocarcinoma.
Sardar M, Recio-Boiles A, Mody K, Karime C, Chandana SR, Mahadevan D, Starr J, Jones J, Borad M, Babiker H. Sardar M, et al. Among authors: mahadevan d. Expert Opin Pharmacother. 2022 Dec;23(18):2079-2089. doi: 10.1080/14656566.2022.2149322. Epub 2022 Nov 28. Expert Opin Pharmacother. 2022. PMID: 36394449 Review.
A call to arms: Unifying the fight against resistance.
Kaushansky A, Hedstrom L, Goldman A, Singh J, Yang PL, Rathod PK, Cynamon M, Wodarz D, Mahadevan D, Tomaras A, Navia MA, Schiffer CA. Kaushansky A, et al. Among authors: mahadevan d. Sci Signal. 2018 Oct 23;11(553):eaav0442. doi: 10.1126/scisignal.aav0442. Sci Signal. 2018. PMID: 30352947 Free PMC article.
Therapeutic trends in pancreatic ductal adenocarcinoma (PDAC).
Chandana S, Babiker HM, Mahadevan D. Chandana S, et al. Among authors: mahadevan d. Expert Opin Investig Drugs. 2019 Feb;28(2):161-177. doi: 10.1080/13543784.2019.1557145. Epub 2018 Dec 16. Expert Opin Investig Drugs. 2019. PMID: 30539678 Review.
AXL-initiated paracrine activation of pSTAT3 enhances mesenchymal and vasculogenic supportive features of tumor-associated macrophages.
Hung CN, Chen M, DeArmond DT, Chiu CH, Limboy CA, Tan X, Kusi M, Chou CW, Lin LL, Zhang Z, Wang CM, Chen CL, Mitsuya K, Osmulski PA, Gaczynska ME, Kirma NB, Vadlamudi RK, Gibbons DL, Warner S, Brenner AJ, Mahadevan D, Michalek JE, Huang TH, Taverna JA. Hung CN, et al. Among authors: mahadevan d. Cell Rep. 2023 Sep 26;42(9):113067. doi: 10.1016/j.celrep.2023.113067. Epub 2023 Sep 1. Cell Rep. 2023. PMID: 37659081 Free PMC article.
Quo vadis, foot & ankle research? A review.
Krause F, Herrera M, Walcher M, Mahadevan D, Michels F. Krause F, et al. Among authors: mahadevan d. Foot Ankle Surg. 2023 Oct;29(7):502-505. doi: 10.1016/j.fas.2023.08.003. Epub 2023 Aug 19. Foot Ankle Surg. 2023. PMID: 37648639 Review.
A comprehensive review of protein kinase inhibitors for cancer therapy.
Kannaiyan R, Mahadevan D. Kannaiyan R, et al. Among authors: mahadevan d. Expert Rev Anticancer Ther. 2018 Dec;18(12):1249-1270. doi: 10.1080/14737140.2018.1527688. Epub 2018 Oct 9. Expert Rev Anticancer Ther. 2018. PMID: 30259761 Free PMC article. Review.
Novel therapeutics for aggressive non-Hodgkin's lymphoma.
Mahadevan D, Fisher RI. Mahadevan D, et al. J Clin Oncol. 2011 May 10;29(14):1876-84. doi: 10.1200/JCO.2010.32.7171. Epub 2011 Apr 11. J Clin Oncol. 2011. PMID: 21483007 Free PMC article. Review.
Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC).
Babiker HM, Karass M, Recio-Boiles A, Chandana SR, McBride A, Mahadevan D. Babiker HM, et al. Among authors: mahadevan d. Expert Opin Investig Drugs. 2019 Jul;28(7):583-592. doi: 10.1080/13543784.2019.1632289. Epub 2019 Jun 21. Expert Opin Investig Drugs. 2019. PMID: 31215251 Free PMC article. Review.
179 results